A 60-year-old patient is diagnosed with lung cancer and staging using the TNM classification system.
Upon assessment, the primary tumor (T) is classified as T2, regional lymph nodes (N) as N1, and no distant metastasis (M0). What does this classification suggest regarding the cancer's characteristics and potential treatment options?

Choice A rationale

Fatigue is a universal side effect associated with both radiation therapy and chemotherapy. In radiation, it results from the energy required for cellular repair and the accumulation of metabolic waste from cell death. In chemotherapy, it is often linked to anemia, systemic inflammation, and the cytotoxic effects on healthy tissues. Because both treatments involve systemic or localized cellular destruction and require significant physiological recovery, fatigue is a common finding shared by both modalities.

Choice B rationale

Night sweats are typically associated with the underlying malignancy itself, such as lymphoma or advanced pancreatic cancer, rather than being a specific side effect of radiation or chemotherapy. While systemic reactions can occur, night sweats are more frequently a symptom of the body's inflammatory response to the tumor or an indication of infection. They are not classified as a standard, predictable side effect of either treatment modality in the same way that cytopenias or enteritis are.

Choice C rationale

Weight loss is a common finding for both radiation and chemotherapy. Radiation to the abdominal area causes gastrointestinal upset and malabsorption, while chemotherapy induces systemic nausea, vomiting, and alterations in taste. Both treatments can lead to a state of cachexia where the body breaks down muscle and fat stores faster than they can be replenished. Nutritional support is a primary concern for patients undergoing these therapies to combat treatment-induced weight loss.

Choice D rationale

Pale skin, or pallor, is associated with both radiation and chemotherapy due to their impact on the bone marrow. Chemotherapy is systemically myelosuppressive, leading to decreased red blood cell production and anemia. While radiation is localized, if the treatment field includes bone-marrow-producing areas like the pelvis or spine, it can also contribute to lower hemoglobin levels. Anemia reduces the oxygen-carrying capacity of the blood, resulting in the visible paleness of the skin and mucous membranes.

Choice A rationale

Adrenal tumors represent only one specific cause of hypercortisolism. This statement is scientifically inaccurate because it fails to account for pituitary adenomas, ectopic ACTH production, or exogenous steroid administration. While adrenal adenomas or carcinomas can lead to Cushing's syndrome by autonomously secreting cortisol, they do not define Cushing's disease. Pathophysiologically, the term syndrome encompasses all etiologies of high cortisol, whereas the disease is specifically linked to the pituitary gland's overproduction of adrenocorticotropic hormone.

Choice B rationale

Cushing's disease is a specific subset of Cushing's syndrome caused by a pituitary adenoma secreting excess adrenocorticotropic hormone. This hormone stimulates the adrenal cortex to produce cortisol. Conversely, Cushing's syndrome is an umbrella term for any condition resulting in prolonged exposure to high cortisol levels, whether endogenous or exogenous. Common causes include long-term glucocorticoid therapy, adrenal tumors, or ectopic ACTH from small cell lung cancer. Normal serum cortisol ranges are 5 to 23 mcg/dL.

Choice C rationale

This choice incorrectly identifies the primary cause of Cushing's disease. Long-term glucocorticoid use is actually the most common cause of exogenous Cushing's syndrome, not the disease itself. Cushing's disease involves a primary internal pathology of the pituitary gland. Furthermore, claiming the syndrome is caused only by adrenal tumors is scientifically false, as it ignores the massive clinical population receiving therapeutic steroids for autoimmune or inflammatory conditions. The underlying molecular mechanism involves the disruption of the hypothalamic-pituitary-adrenal axis.

Choice D rationale

This statement reverses the clinical definitions and causes confusion regarding the terminology. Cushing's disease is never defined by external glucocorticoid administration; that is a hallmark of iatrogenic Cushing's syndrome. The disease refers specifically to the pituitary-driven process. While both involve high cortisol, the diagnostic differentiation is critical because treatment for the disease usually involves transsphenoidal surgery, while treatment for the syndrome depends entirely on the specific underlying trigger, such as tapering off prednisone or removing an adrenal mass.